Related by context. Frequent words. (Click for all words.) 61 aztreonam 60 Clostridium difficile associated 59 refractory chronic lymphocytic 59 Kuvan R 59 R sorafenib tablets 59 diabetic peripheral neuropathic pain 58 hepatitis B HBV 58 TYGACIL 57 constipation IBS C 57 chronic angina 56 Nexavar ® 56 hepatitis C HCV 56 FDA Accepts 56 REMICADE ® 55 orphan medicinal product 55 post herpetic neuralgia PHN 55 fumarate 55 REVLIMID lenalidomide 54 Prulifloxacin 54 Clevudine 54 forodesine 54 ZALBIN 53 Presents Positive 53 opioid induced constipation 53 Application MAA 53 Tygacil 53 Panzem R 53 VALSTAR 53 REVLIMID R 53 Ranexa R 53 Cethromycin 52 FUSILEV 52 Daclizumab 52 Torisel 52 voriconazole 52 Soliris TM eculizumab 52 Actimmune R 52 undergoing coronary angioplasty 51 Ixempra 51 Single Dose 51 Orphan Medicinal Product 51 rilonacept 51 Recombinant Human 51 diabetic neuropathic pain 51 oropharyngeal candidiasis 51 REVLIMID ® 51 pegylated interferon alpha 51 Orphan Drug status 51 Angiox 51 APPROVAL OF 50 Irinotecan 50 C1 esterase inhibitor 50 relapsing forms 50 Pegintron 50 Amrubicin 50 subcutaneous formulation 50 LIFE SCIENCES 50 Initiate Phase 50 Solesta 50 multiple myeloma MM 50 methylnaltrexone 50 painful diabetic neuropathy 50 SUSTIVA 49 J Am Acad 49 central precocious puberty 49 Positive Opinion 49 TORISEL 49 Diabetic Macular Edema 49 Relistor 49 patients undergoing percutaneous 49 osteoarthritis rheumatoid arthritis 49 NYHA Class II 48 Orphan Drug designation 48 ROTATEQ 48 Pivotal Phase III 48 thrombotic disorders 48 desvenlafaxine 48 TNF antagonists 48 Oncaspar 48 Completes Enrollment 48 amrubicin 48 TNF blocker 48 orphan designation 48 castrate resistant prostate cancer 48 Azilect ® 48 secondary hyperparathyroidism 47 Australian Therapeutic Goods 47 Orphan Drug Status 47 application sNDA 47 Marketing Authorisation 47 ISTODAX 46 Fast Track Designation 46 Octreotide 46 lymphoma CTCL 46 SMARTREND 46 Genasense ® 46 Marketing Authorization 46 FENTORA 45 Initiates Phase 45 pancreatic NET 45 Concomitant